Influence of Chimeric Antigen Receptor T-Cell Therapy on Fracture Risk of Patients With Multiple Myeloma. Huynh THN, Clampitt BA, Chose CM, Nester MD, et al. J Am Acad Orthop Surg 2025 Sep 11. doi: 10.5435/JAAOS-D-25-00392.

Read + Share

Amedeo Smart

Independent Medical Education

Huynh THN, Clampitt BA, Chose CM, Nester MD, et al. Influence of Chimeric Antigen Receptor T-Cell Therapy on Fracture Risk of Patients With Multiple Myeloma. J Am Acad Orthop Surg 2025 Sep 11. doi: 10.5435/JAAOS-D-25-00392.
PMID: 40953403